BCIP Life Sciences Associates, LP — SEC Form 4 filings
SEC reporting owner CIK 1702921. 4 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-01-12 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,000,000 shares, $4,030,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 1,000,000 shares @ $4.03 ($4,030,000) in Solid Biosciences Inc., filed 2025-02-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | 10% owner | 2 | 1 leg · 1,000,000 sh · $4,030,000 | — | 2 |
| RAPID MICRO BIOSYSTEMS, INC. (RPID) | 10% owner | 1 | — | — | 3 |
| NewAmsterdam Pharma Co N.V. (NAMS) | 10% owner | 1 | — | — | 1 |
Form 4 filings — BCIP Life Sciences Associates, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) jointly with Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences Partners, LP, Bain Capital Life Sciences Fund, L.P. | Purchase (P): 1,463,000 (derivative) · Purchase (P): 1,463,000 (derivative) · Purchase (P): 1,463,000 (derivative) | EDGAR |
| 2025-02-21 | 4 | Solid Biosciences Inc. (SLDB) jointly with Bain Capital Life Sciences Investors, LLC, BCLS SB Investco, LP, Bain Capital Life Sciences Partners, LP, Bain Capital Life Sciences Fund II, L.P., Bain Capital Life Sciences Investors II, LLC, BCLS II Investco, LP, BCLS II Investco (GP), LLC, BCLS II Equity Opportunities, LP, BCLS II Equity Opportunities GP, LLC | Purchase (P): 1,000,000 @ $4.03 · Purchase (P): 6,444,170 (derivative) @ $4.03 | EDGAR |
| 2024-12-17 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) jointly with Bain Capital Life Sciences Investors, LLC, BCLS Fund III Investments, LP, Bain Capital Life Sciences III General Partner, LLC, Bain Capital Life Sciences Fund III, L.P., BCLS Fund III Investments GP, LLC, BCLS II Investco, LP, BCLS II Investco (GP), LLC, Bain Capital Life Sciences Fund II, L.P., Bain Capital Life Sciences Investors II, LLC | Purchase (P): 1,632,653 (derivative) @ $24.50 | EDGAR |
| 2024-01-12 | 4 | Solid Biosciences Inc. (SLDB) jointly with Bain Capital Life Sciences Investors, LLC, BCLS SB Investco, LP, Bain Capital Life Sciences Partners, LP, Bain Capital Life Sciences Fund II, L.P., Bain Capital Life Sciences Investors II, LLC, BCLS II Investco, LP, BCLS II Investco (GP), LLC | Grant/award (A): 904,160 @ $5.53 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702921 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →